WuXi AppTec’s Corporate Venture Fund was among the participants in a series A round disclosed as the precision medicine startup emerged from stealth.

Co-founded by a professor emeritus at UC Berkeley, Deep Isolation has secured strategic funding from NAC International for its nuclear waste disposal business.

The child developmental therapy provider closed an $18.1m round co-led by Optum Ventures, which will take a board seat at the company.

Gene editing technology developer Metagenomi advances research from UC Berkeley and has raised a series A co-led by Bayer.

Gene editing technology developer Metagenomi closed its first round since emerging from stealth, with Leaps by Bayer the co-lead.

The home improvement services provider increased its overall funding to more than $38m in a round led by Comcast Ventures.

IQM Quantum Computers, a Finland-based quantum computing spinout of Aalto University and VTT Technical Research Centre, attracted a €39m ($46m) series A round from investors, including internet group Tencent.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Partly based on University of Bern research, Synendos aims to restore the endocannabinoid system to treat dysfunction in the central nervous system.

Sinopharm Capital and the WuXi AppTec-backed 6 Dimensions Capital are among the investors in the inflammatory and autoimmune disease drug developer.